Procter & Gamble Health Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on August 29, 2025
PGHL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Procter & Gamble Health Limited held its 58th Annual General Meeting on August 29, 2025, via video conferencing, with five resolutions put to vote. Around 68.15% of outstanding shares (about 11.31 million out of 16.60 million shares) were polled, and all resolutions passed with overwhelming majority. Key items included adoption of FY25 audited financial statements (99.99% in favour), approval of FY25 dividend (99.99% in favour), and re-appointment of Ms. Seema Sambasivan as Non-Executive Director (99.62% in favour). The appointment of Dholakia And Associates as Secretarial Auditors for five years saw the highest dissent at 6.12% against (primarily 25.65% from public institutions), while ratification of Cost Auditor remuneration passed with 99.99% approval. The company had 51,525 shareholders on record date of August 22, 2025.
All five resolutions were approved, reflecting smooth governance and shareholder confidence. The modest institutional dissent on the secretarial auditor appointment is noteworthy but well below the threshold to block the resolution, so no material impact on the stock is expected.